Cochran Jennifer R.
Insider CIK 1872349 · OABI Director · LGND Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OABI OmniAb, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-18 | 20,000 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-06-17 | 2026-06-18 | 20,000 | — | $0 | 185,274 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-06-17 | 2025-06-18 | 20,000 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-06-17 | 2025-06-18 | 20,000 | — | $0 | 165,274 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2025-05-15 | 2025-05-15 | 30,000 | $1.52 | $45.6K | 145,274 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-07-12 | 2024-07-12 | 1,896 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-07-12 | 2024-07-12 | 1,896 | — | $0 | 115,274 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 21,896 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-06-18 | 2024-06-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 1,896 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 113,378 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-07-12 | 2023-07-14 | 1,896 | — | $0 | 21,896 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2023-07-12 | 2023-07-14 | 1,896 | — | $0 | 93,086 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 20,000 | — | $0 | 23,792 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 75,680 | — | $0 | 75,680 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-01-30 | 2023-02-01 | 17,506 | — | $0 | 94,982 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-12-06 | 2022-12-08 | 22,250 | $3.75 | $83.4K | 77,476 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-11-11 | 2022-11-14 | 30,000 | $3.10 | $93.0K | 55,226 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2024-04-23 | 25,518 | — | $0 | 93,378 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer deriv | 2022-11-01 | 2022-11-03 | 4,340 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 19,298 | — | $0 | 19,298 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 37,840 | — | $0 | 37,840 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer | 2022-11-01 | 2022-11-03 | 1,004 | — | $0 | 1,161 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2022-11-03 | 25,226 | — | $0 | 25,226 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 2,165 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-07-12 | 2021-07-14 | 4,508 | — | $0 | 4,508 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-07-12 | 2021-07-14 | 1,161 | — | $0 | 1,161 | SEC↗ |